TCTMD

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

BARCELONA, Spain—Among all the big trials airing results at the European Society of Cardiology (ESC) Congress 2017, one tiny stent—and its performance—could have slipped through the cracks. Earlier ...
TCTMD

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Final 5-year follow-up from the BIOFLOW V trial continues to show advantages for the ultrathin-strut bioresorbable-polymer Orsiro DES (Biotronik) over the thin-strut, durable-polymer Xience (Abbott), ...
Healio

BIOFLOW-II: Biodegradable polymer DES noninferior to durable polymer DES at 9 months

Please provide your email address to receive an email when new articles are posted on . These results, Windecker said during his presentation, “will need to be extended to larger randomized trials ...